This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Ramarao Dodda: Innovator in Pharmaceutical Chemistry
Introduction
Ramarao Dodda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work has implications for the treatment of various medical conditions, showcasing his commitment to advancing healthcare through scientific innovation.
Latest Patents
Ramarao Dodda holds a patent for a process related to the preparation of empagliflozin. This patent, titled "Process for the preparation of empagliflozin," discloses an improved method for synthesizing this important pharmaceutical compound. The patent also introduces novel intermediates of formulas (13) and (14) for the preparation of empagliflozin, wherein Rand Rare independently hydrogen or hydroxyl protecting groups. This innovation is crucial for enhancing the efficiency and effectiveness of empagliflozin production.
Career Highlights
Ramarao Dodda is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan allows him to apply his expertise in pharmaceutical chemistry to develop new and improved medications. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Ramarao has collaborated with talented professionals, including Vipin Kumar Kaushik and Jagan Mohana Chary Tummanepally. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical processes.
Conclusion
Ramarao Dodda's contributions to pharmaceutical chemistry, particularly through his patent for empagliflozin, highlight his role as an innovator in the field. His work at Mylan Laboratories Limited and collaborations with other professionals further emphasize his commitment to advancing healthcare solutions.
